Jussila L - Search Results

1

Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3.

Mäkinen T, Jussila L, Veikkola T, Karpanen T, Kettunen MI, Pulkkanen KJ, Kauppinen R, Jackson DG, Kubo H, Nishikawa S, Ylä-Herttuala S, Alitalo K. Mäkinen T, et al. Among authors: jussila l. Nat Med. 2001 Feb;7(2):199-205. doi: 10.1038/84651. Nat Med. 2001. PMID: 11175851

2

Vascular growth factors and lymphangiogenesis.

Jussila L, Alitalo K. Jussila L, et al. Physiol Rev. 2002 Jul;82(3):673-700. doi: 10.1152/physrev.00005.2002. Physiol Rev. 2002. PMID: 12087132 Free article. Review.

3

Lymphangiogenesis and cancer metastasis.

Stacker SA, Achen MG, Jussila L, Baldwin ME, Alitalo K. Stacker SA, et al. Among authors: jussila l. Nat Rev Cancer. 2002 Aug;2(8):573-83. doi: 10.1038/nrc863. Nat Rev Cancer. 2002. PMID: 12154350 Review.

4

Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice.

Veikkola T, Jussila L, Makinen T, Karpanen T, Jeltsch M, Petrova TV, Kubo H, Thurston G, McDonald DM, Achen MG, Stacker SA, Alitalo K. Veikkola T, et al. Among authors: jussila l. EMBO J. 2001 Mar 15;20(6):1223-31. doi: 10.1093/emboj/20.6.1223. EMBO J. 2001. PMID: 11250889 Free PMC article.

5

Molecular regulation of lymphangiogenesis and targets for tissue oedema.

Karkkainen MJ, Jussila L, Ferrell RE, Finegold DN, Alitalo K. Karkkainen MJ, et al. Among authors: jussila l. Trends Mol Med. 2001 Jan;7(1):18-22. doi: 10.1016/s1471-4914(00)01864-5. Trends Mol Med. 2001. PMID: 11427983 Review.

6

A model for gene therapy of human hereditary lymphedema.

Karkkainen MJ, Saaristo A, Jussila L, Karila KA, Lawrence EC, Pajusola K, Bueler H, Eichmann A, Kauppinen R, Kettunen MI, Yla-Herttuala S, Finegold DN, Ferrell RE, Alitalo K. Karkkainen MJ, et al. Among authors: jussila l. Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12677-82. doi: 10.1073/pnas.221449198. Epub 2001 Oct 9. Proc Natl Acad Sci U S A. 2001. PMID: 11592985 Free PMC article.

7

Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing.

Paavonen K, Puolakkainen P, Jussila L, Jahkola T, Alitalo K. Paavonen K, et al. Among authors: jussila l. Am J Pathol. 2000 May;156(5):1499-504. doi: 10.1016/S0002-9440(10)65021-3. Am J Pathol. 2000. PMID: 10793061 Free PMC article.

8

Vascular endothelial growth factor-C and its receptor VEGFR-3 in the nasal mucosa and in nasopharyngeal tumors.

Saaristo A, Partanen TA, Arola J, Jussila L, Hytönen M, Mäkitie A, Vento S, Kaipainen A, Malmberg H, Alitalo K. Saaristo A, et al. Among authors: jussila l. Am J Pathol. 2000 Jul;157(1):7-14. doi: 10.1016/S0002-9440(10)64510-5. Am J Pathol. 2000. PMID: 10880369 Free PMC article.

9

Involvement of vascular endothelial growth factor receptor-3 in maintenance of integrity of endothelial cell lining during tumor angiogenesis.

Kubo H, Fujiwara T, Jussila L, Hashi H, Ogawa M, Shimizu K, Awane M, Sakai Y, Takabayashi A, Alitalo K, Yamaoka Y, Nishikawa SI. Kubo H, et al. Among authors: jussila l. Blood. 2000 Jul 15;96(2):546-53. Blood. 2000. PMID: 10887117 Free article.

10

VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues.

Partanen TA, Arola J, Saaristo A, Jussila L, Ora A, Miettinen M, Stacker SA, Achen MG, Alitalo K. Partanen TA, et al. Among authors: jussila l. FASEB J. 2000 Oct;14(13):2087-96. doi: 10.1096/fj.99-1049com. FASEB J. 2000. PMID: 11023993

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

24 results

Search Page